TALARIS THERAPEUTICS INC's ticker is TALS and the CUSIP is 87410C104. A total of 57 filers reported holding TALARIS THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $691,344 | +0.4% | 246,030 | +8.7% | 0.00% | 0.0% |
| Q2 2023 | $688,302 | +1228.3% | 226,415 | +721.4% | 0.00% | – |
| Q1 2023 | $51,820 | -51.5% | 27,564 | -73.7% | 0.00% | – |
| Q4 2022 | $106,765 | +14.8% | 104,672 | +197.5% | 0.00% | – |
| Q3 2022 | $93,000 | -36.3% | 35,178 | +225.8% | 0.00% | – |
| Q3 2021 | $146,000 | -77.9% | 10,796 | -76.0% | 0.00% | -100.0% |
| Q2 2021 | $661,000 | – | 44,967 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Qiming U.S. Ventures Management, LLC | 2,932,606 | $8,240,623 | 10.94% |
| BML Capital Management, LLC | 2,000,000 | $5,620,000 | 5.16% |
| Nantahala Capital Management | 2,953,129 | $8,298,292 | 0.71% |
| GREAT POINT PARTNERS LLC | 1,000,000 | $2,810,000 | 0.51% |
| Acuitas Investments, LLC | 194,547 | $546,677 | 0.32% |
| Affinity Asset Advisors, LLC | 400,000 | $1,124,000 | 0.32% |
| RA Capital Management | 2,403,238 | $6,753,099 | 0.13% |
| Artal Group S.A. | 914,262 | $2,569 | 0.11% |
| Blackstone Inc. | 8,089,315 | $22,730,975 | 0.10% |
| QVT Financial LP | 589,314 | $1,655,972 | 0.09% |